First-of-its-kind study by NHCS researchers shows an adverse association between heart muscle scarring (also known as myocardial fibrosis) and patients with hypertension, detected non-invasively...
Blinding macrophages to octanal subsided inflammation and reversed disease progression in mice, opening up the possibility of blocking olfactory receptors of macrophages to treat atherosclerosis in...
An interview with Dr. Prashanth Subramanian, Chief Scientific Officer for Novartis Singapore on their newly approved cholesterol drug. High cholesterol has been associated with increased...
Information presented at AHA's Scientific Sessions provides insights on protecting the heart at every stage of cancer treatment. Developments in cancer treatment and care have dramatically improved...
Multi-national intervention trial to reduce and better control blood pressure produces “clinically meaningful” results through multifactorial approach. High blood pressure or hypertension is a...
Using information from the Surveillance Epidemiology and End Results (SEER) database, it was revealed that 11 percent of cancer patients died from cardiovascular disease. Dr Nicholas Zaorsky, a...
Almost one-third of Chinese adults face the challenge of abdominal obesity, or excess fat around the midsection, according to recent research published by Obesity Journal. Professor Gao Runlin, an...
Researchers from Duke-NUS have developed the first genome-wide dataset on protein translation during fibroblast activation during cardiac fibrosis. Using cutting-edge technologies, researchers at...
Prescription omega-3 fatty acid medication reduces triglyceride levels by 20-30 percent among the majority of people who require treatment for high triglyceride levels, according to a science...
Bayer, in partnership with NUS Enterprise, launched the Healthy Hearts, Healthy Aging Asia Pacific Report to foster multi-stakeholder collaboration in embracing innovative therapies and technologies...
Designed and structured as an educational platform for all members of the interventional community to benefit, the inaugural edition of the official course of the Asia Pacific Society of...
Initiative to drive the adoption of health innovation which enables long-term prevention of stroke, heart attacks and other serious cardiovascular events. By 2050, one in four people in Asia and the...
